This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Recent studies find oral decongestant phenylephrine ineffective, posing dilemma for FDA. Reform may be needed in the OTC drug approval process.
Last month, an FDA advisory panel found that drugs with phenylephrine as the only active ingredient weren’t effective, but not unsafe.
